Botox and filler ads in Dubai need separate checks for the clinic’s applicable local advertising requirements and the platform’s policies. DHA has public social-media advertising standards, while Google also restricts certain drug content and health-related targeting. Approval in one system does not establish approval in the other.
There are several decisions inside one advertisement
A clinic may want to promote an injectable consultation with a price, a practitioner video and a booking link. Those elements raise different questions: is the service within the clinic’s scope, is the wording supportable, is the imagery acceptable, and will the platform permit this content and targeting?
Start by mapping those questions with the clinic’s responsible staff. A media buyer can identify a platform rejection; clinical and regulatory decisions belong with the people authorised to make them. This guide is a campaign-planning checklist, not approval for a particular advertisement.
Check the current DHA standards
Use the DHA social-media medical advertising standards as a primary reference. They cover professional responsibilities, content and the use of images. Ask the clinic to confirm the requirements and approvals that apply to its exact service, licence and proposed channel.
Keep a copy of the final approved asset, its destination and the date it was cleared internally. A later edit to the caption, price or landing page may change what the reviewer examined. Build review time into the production schedule.
Google’s drug rules need their own review
Google lists botulinum toxin among monitored prescription drug terms. Its healthcare and medicines policy includes restrictions that depend on content, advertiser category and country. Do not assume a clinic’s local licence gives unrestricted permission to advertise a drug term through Google.
Check the live policy against the intended ad and website before committing spend. If a rejection is unclear, use the account’s review or appeal process. Changing spelling, concealing content or showing reviewers a different destination is not a sound compliance strategy.
Review promises and patient imagery carefully
Have clinical staff review any statement about results, suitability, duration or risks. Avoid absolute language such as “guaranteed,” “risk-free” or “perfect results.” Marketing copy should explain the consultation and service honestly without implying the same outcome for everyone.
Patient consent and permission to use an image do not automatically make that image suitable for every advertising channel. Before-and-after formats, procedure footage and close-ups require their own assessment. Use our before-and-after advertising guide to frame the questions, then check the current rules for the proposed placement.
What should an internal review checklist include?
| Item | Question | Record to retain |
|---|---|---|
| Service | Is the advertised service accurate for this facility and practitioner? | Clinic confirmation of the service facts |
| Claims | Can the clinic support every statement in the copy? | Reviewed wording and supporting information |
| Images | Are permissions and channel suitability checked? | Consent where applicable and asset review |
| Price | Are consultation terms and exclusions clear? | Final offer details and validity dates |
| Destination | Does the landing page match the reviewed advertisement? | Saved page version or review record |
| Platform | Does the content and targeting fit the current policy? | Policy references and account decision |
Do not build audiences from sensitive treatment interest
Google’s health in personalised advertising policy limits advertiser-curated audiences for sensitive health interests, including invasive procedures and injections. A person viewing an injectable page is not a signal to use casually in remarketing or customer-list targeting.
Review what tracking sends, not just what a dashboard displays. URLs, form values and event labels can reveal treatment interest. Keep clinical enquiries separate from advertising systems and have the integration reviewed for the data and permissions involved.
Make the landing page useful
The page should identify the real clinic and branch, show relevant practitioner information, explain the appointment process and give an accurate next step. It should answer practical questions without promising eligibility or results before an assessment.
Reception also needs the same offer terms. If a customer sees one price online and hears another on the phone, improved targeting will not solve the trust problem. Review the page and the booking script together.
What to do when the advertisement is rejected
Save the exact rejection reason and determine whether it concerns the ad, destination, targeting or account. Correct the identified problem and preserve the review history. If the decision appears mistaken, appeal with the relevant facts through the platform.
For a broader campaign review, see why Dubai clinic ads get rejected or AdGrow’s Botox and filler marketing services. The useful first step is a reviewed plan for your actual service and channel.
Frequently asked questions
Can a Dubai clinic advertise Botox on Google?
Eligibility depends on Google’s current healthcare and drug policies, the content, country and advertiser category. Botulinum toxin appears in Google’s monitored drug list, so check the exact proposed campaign rather than assuming eligibility.
Does patient consent make before-and-after ads acceptable?
Consent is one requirement to assess, not blanket advertising permission. Review the imagery against the applicable local requirements and platform policy.
Does platform approval mean the advertisement meets DHA requirements?
No. Platform review and the clinic’s local obligations are separate checks. Retain the relevant internal and regulatory review records.
Sources and further reading
- DHA: medical advertising standards
- Google: healthcare and medicines
- Google: monitored prescription drug terms
- Google: health in personalised advertising
Sources checked on 13 October 2026.